|
시장보고서
상품코드
2075242
줄기세포 연골 재생 시장 : 줄기세포 유형별, 치료법별, 최종사용자별, 지역별 및 지역별Stem Cell Cartilage Regeneration Market, by Stem Cell Type, by Treatment, By End User and by Region, and By Geography |
||||||
줄기세포 연골 재생 시장은 2026년에 5억 2,710만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 9억 8,860만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 9.4%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 5억 2,710만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 9.40% | 2033년 시장 규모 예측 : | 9억 8,860만 달러 |
연골 재생에서 줄기세포는 다능성 분화 및 자가복제 능력을 갖추고 있으며, 시드 세포로 활용하기에 이상적인 선택지입니다. 재생의료 산업의 성장과 각종 세포 치료법 개발에 따른 줄기세포 수요 증가가 예측 기간 중 시장 성장을 촉진할 것으로 전망됩니다. 간엽계 줄기세포는 연골 재생 분야에서 가장 널리 활용되고 있는 줄기세포입니다. 또한 성체 줄기세포는 연골, 뼈, 지방 또는 연조직으로 분화할 가능성이 있습니다. 줄기세포를 이용한 치료법은 연골 재생에 있으며, 기능적 대체의 중요한 초점이 되고 있습니다. 성체 줄기세포는 지방 조직이나 골수에서 비침습적인 방법으로 채취할 수 있습니다. 지방 유래 줄기세포는 연골로 분화할 능력이 뛰어나며, 골수 유래 줄기세포보다 그 수가 더 많은 것으로 확인되었습니다.
시장 역학
연구개발 활동의 활성화가 예측 기간 중 시장을 촉진할 것으로 예상됩니다. 예를 들어 2020년 8월 'Stanford Medicine'지에 게재된 자료에 따르면 스탠퍼드 대학교 의과대학 연구진은 쥐와 인간의 조직에서 관절에 있는 연골 쿠션을 재생하는 방법을 발견했습니다. 스탠퍼드 대학교 연구진은 먼저 관절 조직에 경미한 손상을 입힌 뒤, 손상이 치유되는 과정에서 화학적 신호를 이용해 골격 줄기세포의 성장을 유도함으로써 관절 연골을 재생시키는 방법을 규명했습니다.
본 연구의 주요 특징 :
- 이 연구는 다양한 부문에서 잠재적인 매출 기회를 밝혀내고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 줄기세포 연골 재생 시장의 주요 기업을 분석하고 있습니다.
- 이 '세계의 줄기세포를 활용한 연골 재생 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 줄기세포 연골 재생 시장 분석에 사용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 줄기세포 연골 재생 시장
제5장 세계의 줄기세포 연골 재생 시장 : 줄기세포 유형별, 2021-2033년
제6장 세계의 줄기세포 연골 재생 시장 : 치료법별, 2021-2033년
제7장 세계의 줄기세포 연골 재생 시장 : 최종사용자별, 2021-2033년
제8장 세계의 줄기세포 연골 재생 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.07.08Stem Cell Cartilage Regeneration Market is estimated to be valued at USD 527.1 Mn in 2026 and is expected to reach USD 988.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 527.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.40% | 2033 Value Projection: | USD 988.6 Mn |
In cartilage regeneration, stem cells have the potential for multiple differentiation and self-replication, making them an ideal choice for use as seed cells. The growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies are expected to drive the growth of the market over the forecast period. Mesenchymal stem cells are the most widely applied stem cells in the field of cartilage regeneration. Furthermore, adult stem cells have the potential to differentiate into cartilage, bone, fat or soft tissue. Stem cell-based therapy has become a key focus in the functional replacement of cartilage regeneration. Adult stem cells can be extracted by minimally invasive methods from fat tissue and bone marrow. Fat-derived stem cells exhibit an enhanced ability to differentiate into cartilage and are found in higher numbers than bone marrow.
Market Dynamics
Increasing research and development activities is expected to drive the market over the forecast period for instance, in August 2020, data was published in the Stanford Medicine journal, according to that, researchers at the Stanford University School of Medicine have discovered a way to regenerate, in mice and human tissue, the cushion of cartilage found in joints. The Stanford researchers figured out how to regrow articular cartilage by first causing slight injury to the joint tissue, then using chemical signals to steer the growth of skeletal stem cells as the injuries heal.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global stem cell cartilage regeneration market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study are Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation. Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global stem cell cartilage regeneration market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell cartilage regeneration market
Detailed Segmentation:
- Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type (Revenue, USD Mn, 2021 - 2033)
- Hematopoietic Stem Cells (HSCs)
- Pluripotent Stem Cells (iPSC/ESCs)
- Mesenchymal Stem Cells (MSCs)
- Global Stem Cell Cartilage Regeneration Market, By Treatment (Revenue, USD Mn, 2021 - 2033)
- Microfracture
- Osteochondral Transplant
- Autologous Chondrocyte Implantation
- Stem Cell Injections
- Global Stem Cell Cartilage Regeneration Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Global Stem Cell Cartilage Regeneration Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country:
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
- Company Profiles
- Theracell Advanced Biotechnology Ltd *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Orthocell Ltd.
- Xintela AB
- CellGenix GmbH
- Merck KGaA
- Osiris Therapeutics, Inc.
- BioTissue SA
- Vericel Corporation
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Stem Cell Type
- Market Snapshot, By Treatment
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product Launch
- Technological Advancements
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
4. Global Stem Cell Cartilage Regeneration Market
- Economic Impact
- Impact on Supply and Demand
5. Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type, 2021 €" 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hematopoietic Stem Cells (HSCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Pluripotent Stem Cells (iPSC/ESCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Mesenchymal Stem Cells (MSCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
6. Global Stem Cell Cartilage Regeneration Market, By Treatment, 2021 €" 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Microfracture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Osteochondral Transplant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Autologous Chondrocyte Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Stem Cell Injections
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (US$ Million)
7. Global Stem Cell Cartilage Regeneration Market, By End User, 2021 €" 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, ((US$) Million)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, ((US$) Million)
8. Global Stem Cell Cartilage Regeneration Market, By Region, 2021 €" 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022€"2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 €" 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Theracell Advanced Biotechnology Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Orthocell Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Xintela AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CellGenix GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Osiris Therapeutics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioTissue SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
